首页> 美国卫生研究院文献>other >HLA-MATCHED SIBLING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR FANCONI ANEMIA: COMPARISON OF IRRADIATION AND NON-IRRADIATION CONTAINING CONDITIONING REGIMENS
【2h】

HLA-MATCHED SIBLING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR FANCONI ANEMIA: COMPARISON OF IRRADIATION AND NON-IRRADIATION CONTAINING CONDITIONING REGIMENS

机译:范可尼贫血的HLA标记的同种异体造血干细胞移植:含条件辐照和非辐照条件的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Related to the underlying DNA repair defect that is the hallmark of Fanconi anemia (FA), preparatory regimen related toxicities have been obstacles to hematopoietic cell transplantation (HCT). In an attempt to decrease the risk and severity of regimen-related toxicities, non-irradiation regimens have been explored. The aim of this study is to compare outcomes after irradiation and non-irradiation regimens in 148 FA patients and identify risk factors impacting upon HCT outcomes. Hematopoietic recovery, acute and chronic graft-versus-host disease and mortality were similar after irradiation and non-irradiation regimens. In both groups recipient aged >10 years, prior use of androgens and cytomegalovirus seropositivity in either the donor or recipient were associated with higher mortality. With median follow ups >5 years, the 5-year probability of overall survival, adjusted for factors impacting overall mortality was 78% and 81% after irradiation and non-irradiation regimens, p=0.61. In view of the high risk of cancer and other radiation related effects on growth and development, these results support the use of non-irradiation preparatory regimens. As the peak time for developing solid tumors after HCT is 8–9 years, longer follow up is required before definitive statements can be made regarding the impact of non-irradiation regimens on cancer risk.
机译:与潜在的DNA修复缺陷有关,这是Fanconi贫血(FA)的标志,与治疗方案相关的毒性一直是造血细胞移植(HCT)的障碍。为了降低方案相关毒性的风险和严重性,已经探索了非辐照方案。这项研究的目的是比较148名FA患者的放疗和未放疗方案后的结局,并确定影响HCT结局的危险因素。放疗和不放疗后,造血恢复,急性和慢性移植物抗宿主病和死亡率相似。在两组年龄均大于10岁的受者中,在供者或受者中既往使用雄激素和巨细胞病毒血清阳性与更高的死亡率相关。中位随访时间> 5年,经放射线和非放射线方案校正后影响总死亡率的因素后,5年总体存活率分别为78%和81%,p = 0.61。鉴于癌症和其他辐射相关的生长和发育相关风险的高风险,这些结果支持使用非辐射预备方案。由于HCT发生实体瘤的高峰时间为8–9年,因此在确定非照射方案对癌症风险的影响之前,需要更长的随访时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号